Drugs / Acmella Oleracea
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT07478640 | Apr 2024 → Jun 2025 | dentin sensitivity | Federal University of Pará | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05141864 Comparator | Mar → Jun 2021 | — | Universidade do Vale do Sapucai | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acmella Oleracea | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07478640 ↗ |
| Known as | jambu | “The bioadhesive film of Acmella Oleracea (jambu) will be applied to the vestibular surfaces of the upper and lower central and lateral incisors, canines, and premolars, like a...” NCT07478640 ↗ |
| Route | Topical | “for topical application as a tape on teeth prior to teeth whitening with hydrogen peroxide” NCT07478640 ↗ |